Difference between revisions of "Chlorambucil (Leukeran)"
m (→References) |
Warner-admin (talk | contribs) m (Text replacement - "Category:Oral chemotherapy" to "Category:Oral medications") |
||
Line 40: | Line 40: | ||
[[Category:Drug index]] | [[Category:Drug index]] | ||
[[Category:Chemotherapy]] | [[Category:Chemotherapy]] | ||
− | [[Category:Oral | + | [[Category:Oral medications]] |
[[Category:Nitrogen mustards]] | [[Category:Nitrogen mustards]] |
Revision as of 16:50, 25 July 2017
General information
Class/mechanism: Nitrogen mustard, alkylating agent. Interferes with DNA replication and induces apoptosis through accumulation of p53 in the cytosol and downstream activation of the apoptosis promoter Bax.[1][2]
Route: PO
Extravasation: n/a
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.[1]
Diseases for which it is used
- Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL)
- Hodgkin lymphoma
- Follicular lymphoma
- Mantle cell lymphoma
- Marginal zone lymphoma
- Waldenström macroglobulinemia
Patient drug information
- Chlorambucil (Leukeran) patient drug information (Chemocare)[3]
- Chlorambucil (Leukeran) patient drug information (UpToDate)[4]
History of changes in FDA indication
- 3/18/1957: Initial FDA approval
Also known as
Precise Name: Chlorambucil (RXCUI 2346)
Synonyms | |||||||
---|---|---|---|---|---|---|---|
Chloraminophene | Chlorambusil | Chlorobutin | Chlorbutin | Leukeran | Linfoxan |
References
- Drug index
- Chemotherapy
- Oral medications
- Nitrogen mustards
- Alkylating agents
- Chronic lymphocytic leukemia (CLL) and Small lymphocytic lymphoma (SLL) medications
- Hodgkin lymphoma medications
- Follicular lymphoma medications
- Mantle cell lymphoma medications
- Marginal zone lymphoma medications
- Waldenström macroglobulinemia medications
- Drugs FDA approved in 1957
- WHO Essential Cancer Medicine